Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Pfizer naming Diarmuid Lynch .
Filed returns
7
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2025 | Pfizer | Trade | Raise concern about the impact of potential tariffs on pharmaceutical manufacturing and supply of medicines to patients globally (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2024 | Pfizer | Economic Development and Industry | Life Science Strategy and Industrial Policy (Public policy or programme) | 8 | On lobbying.ie |
| Sep–Dec 2024 | Pfizer | Health | Ireland's medicine reimbursement system and funding for access to new medicines and vaccines (Matters involving public funds) | 15 | On lobbying.ie |
| May–Aug 2023 | Pfizer | EU Affairs | EU Pharmaceutical Legislation proposals (Legislation) | 5 | On lobbying.ie |
| May–Aug 2023 | Pfizer | Health | Ireland's reimbursement system and funding for new medicines (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2022 | Pfizer | Economic Development and Industry | COVID-19 Trips waiver - vaccines and therapeutics (Public policy or programme) | 17 | On lobbying.ie |
| Jan–Apr 2022 | Pfizer | Economic Development and Industry | Proposed COVID-19 Trips waiver (Public policy or programme) | 12 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Economic Development and Industry | 3 | 42.9% | |
| Health | 2 | 28.6% | |
| EU Affairs | 1 | 14.3% | |
| Trade | 1 | 14.3% |